CooperVision
CooperVision is a world leader in eye care. They make many products to help people see clearly. Their soft contact lenses are used by people everywhere. One of their main goals is to slow down myopia, or nearsightedness, in children. They use new science and tools to make this happen. CooperVision works with parents, kids, and eye doctors to protect healthy vision for life.
CooperVision sponsored blogs.
CooperVision myopia management products
Myopia management products listed by Myopia Profile have been specifically designed for myopia control or myopia management in children, and have some form of regulatory approval or marking for this form of use. They also have randomized controlled trial research data supporting their efficacy, unless otherwise noted. It is up to the individual eye care practitioner to be aware of regulatory requirements for prescribing in their country of practice, and also be aware that not all products are available in all countries.
Biofinity® Multifocal
These lens designs were originally made for presbyopia and are not approved for myopia control in children. However, Biofinity® Multifocal lenses may be considered off-label for children who cannot be fitted with, or whose prescriptions are too high for, other soft contact lens options. One clinical trial showed that the +2.50 D (center-distance) design slowed myopia progression and was well tolerated by children. The +1.50 D design, however, was not effective. Another study using historical controls showed that Proclear® Multifocal +2.00 D (center-distance) lenses also helped slow myopia progression.
A toric design is available, but it has not been tested for myopia control in children with astigmatism. Monthly replacement lenses like these can be suitable for children who understand and can maintain good contact lens hygiene.
DreamLite® MC
DreamLite® MC orthokeratology lenses by CooperVision are an approved option in Europe for slowing myopia progression in children and young adults. They are currently available in Europe and China. DreamLite® MC is part of CooperVision’s global portfolio of myopia management solutions, which also includes MiSight® 1 day, SightGlass Vision™, and Paragon CRT®.
MiSight® 1 day
MiSight® 1 day is a safe and well-tolerated soft contact lens. It has the strongest and longest research record of any lens used for myopia control. Doctors often recommend it as a first choice for both correcting and slowing myopia.
MiSight® 1 day is also the first and only lens approved by the U.S. FDA for myopia control. Research has shown it to be safe, effective, and well accepted by children with myopia. Two clinical trials, lasting two and three years, proved its benefits. Published results now cover up to six years, with reports extending to seven years, giving MiSight® the most complete dataset of any myopia control soft lens.
Paragon CRT®
Paragon CRT® contact lenses are orthokeratology lenses that have been used for myopia management for more than 20 years. They were the first FDA-approved overnight wear lenses for temporarily reducing myopia. Paragon CRT lenses can be fitted empirically, with a diagnostic set, or using corneal topography. With strong scientific evidence supporting orthokeratology, these lenses are considered a first-line treatment for children with myopia.